6.57BUSD
1.42
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US75615P1030
CUSIP
75615P103
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.31
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-2.6
Wall Street Target Price
172.40
EPS Estimate Current Year
-10.21
EPS Estimate Next Year
-4.77
EPS Estimate Current Quarter
-2.88
EPS Estimate Next Quarter
-2.45
Most Recent Quarter
-
Revenue TTM
23,480,000
Gross Profit TTM
-167,627,000
EBITDA
-340,537,984
Profit Margin
0.00%
Return On Assets TTM
-37.66%
Return On Equity TTM
-112.39%
Revenue Per Share TTM
0.635
Qtly Revenue Growth YOY
2885.00%
Diluted Eps TTM
-2.6
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
414.7289
Price Book MRQ
285.9438
Enterprise Value Revenue
316
Enterprise Value EBITDA
-3
31.85
2.84%66.64
2.63%558.91
2.45%466.25
1.71%547.60
0.00%161.72
0.00%83.82
0.00%202.16
0.00%101.15
-0.15%228.74
-0.07%